Trial | NCT02621502  Report issue

Title

Quinoa Effects on Glycemic Index and Satiety
Pilot Study to Evaluate the Glycemic Index, and the Satiating Effect Using Different Quinoa Varieties in a Group of Healthy Overweight Subjects

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    glucose quinoa ...

  • Study Participants

    8
The purpose of this study is to to assess the glycemic index and the satiating properties of different Quinoa varieties, using a Visual Analogue Scale in a sample of healthy overweight subjects.
Pilot study to evaluate the glycemic index, and the satiating effect using different Quinoa varieties in a group of healthy overweight subjects.
Study Started
Sep 30
2014
Primary Completion
Dec 31
2014
Study Completion
Jan 31
2015
Last Update
Dec 03
2015
Estimate

Dietary Supplement Quinoa variety 1

On the intervention day, the volunteers will consume the Quinoa Variety 1. Then during minutes 0, 15, 30, 45, 60, 90, 120, 180, 240 and 260 two types of methodologies were conducted: In minutes 0, 15, 30, 45, 60, 90 and 120, blood samples were collected. In minutes 0, 15, 30, 60, 90, 120, 180, 240 and 260, volunteers completed the Visual analogue scale questionnaire.

Dietary Supplement Quinoa variety 2

On the intervention day, the volunteers will consume the Quinoa Variety 2. Then during minutes 0, 15, 30, 45, 60, 90, 120, 180, 240 and 260 two types of methodologies were conducted: In minutes 0, 15, 30, 45, 60, 90 and 120, blood samples were collected. In minutes 0, 15, 30, 60, 90, 120, 180, 240 and 260, volunteers completed the Visual analogue scale questionnaire.

Dietary Supplement Quinoa variety 3

On the intervention day, the volunteers will consume the Quinoa Variety 3. Then during minutes 0, 15, 30, 45, 60, 90, 120, 180, 240 and 260 two types of methodologies were conducted: In minutes 0, 15, 30, 45, 60, 90 and 120, blood samples were collected. In minutes 0, 15, 30, 60, 90, 120, 180, 240 and 260, volunteers completed the Visual analogue scale questionnaire.

Dietary Supplement Quinoa variety 4

On the intervention day, the volunteers will consume the Quinoa Variety 4. Then during minutes 0, 15, 30, 45, 60, 90, 120, 180, 240 and 260 two types of methodologies were conducted: In minutes 0, 15, 30, 45, 60, 90 and 120, blood samples were collected. In minutes 0, 15, 30, 60, 90, 120, 180, 240 and 260, volunteers completed the Visual analogue scale questionnaire.

Dietary Supplement Anhydrous Glucose

On the intervention day, the volunteers will consume the control product. Then during minutes 0, 15, 30, 45, 60, 90, 120, 180, 240 and 260 two types of methodologies were conducted: In minutes 0, 15, 30, 45, 60, 90 and 120, blood samples were collected. In minutes 0, 15, 30, 60, 90, 120, 180, 240 and 260, volunteers completed the Visual analogue scale questionnaire.

Quinoa variety 1 Experimental

1 dose of Quinoa Variety 1 orally. The product is provided in a mix-pack together with water (100mL). This flexible container is capable of maintaining separate purified water (100 mL) and the experimental powder product in the same package. Both products can be easily mixed by breaking the inner seal. Volunteers had a maximum of 10 minutes to consume the product.

Quinoa variety 2 Experimental

1 dose of Quinoa Variety 2 orally. The product is provided in a mix-pack together with water (100mL). This flexible container is capable of maintaining separate purified water (100 mL) and the experimental powder product in the same package. Both products can be easily mixed by breaking the inner seal. Volunteers had a maximum of 10 minutes to consume the product.

Quinoa variety 3 Experimental

1 dose of Quinoa Variety 3 orally. The product is provided in a mix-pack together with water (100mL). This flexible container is capable of maintaining separate purified water (100 mL) and the experimental powder product in the same package. Both products can be easily mixed by breaking the inner seal. Volunteers had a maximum of 10 minutes to consume the product.

Quinoa variety 4 Experimental

1 dose of Quinoa Variety 4 orally. The product is provided in a mix-pack together with water (100mL). This flexible container is capable of maintaining separate purified water (100 mL) and the experimental powder product in the same package. Both products can be easily mixed by breaking the inner seal. Volunteers had a maximum of 10 minutes to consume the product.

Anhydrous Glucose Active Comparator

1 dose of Anhydrous Glucose orally. . The product is provided in a mix-pack together with water (100mL). This flexible container is capable of maintaining separate purified water (100 mL) and the control powder product in the same package. Both products can be easily mixed by breaking the inner seal. Volunteers had a maximum of 10 minutes to consume the product.

Criteria 

Inclusion Criteria:

Men and women from 18 to 65 years old.
Body mass index (BMI) ≥25 and <30 kg/m2.
Adequate cultural level and understanding for the clinical trial.
Signed informed consent

Exclusion Criteria:

Individuals with BMI ≥30 or <25 kg/m2
Vegetarians or individuals with a fiber intake ≥30 g/day
Individuals diagnosed with Diabetes Mellitus
Individuals with dyslipidemia on pharmacological treatment
Individuals with hypertension on pharmacological treatment
Smokers or heavy drinking individuals (>2-3 servings/day in men and > 1 serving/day in women (1 serving=1 glass of wine or 1 bottle of beer))
Individuals with large weight fluctuations or who have undergone in recent months a weight loss diet
Individuals with gastrointestinal diseases that affect the digestion or the absorption of nutrients
Individuals receiving at least the preceding 2 months a pharmacological treatment that modifies the lipid profile (for example, statins, fibrates, diuretics, corticosteroids, oral antidiabetic medications)
Pregnant or breastfeeding women
Women with menstrual irregularities (absence of menstrual cycle at least 2 months prior)
Individuals with intense physical activity
No Results Posted